| Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device. |
| |
| Trade Name | BOSTON ORTHOKERATOLOGY (OPRIFOCON A) SHAPING LENSES FOR OVERNIGHT WEAR FOR B&L VISION SHAPING TREATMENT |
| Classification Name | lens, contact, orthokeratology, overnight |
| Generic Name | oprifocon a rigid gas permeable contact lenses |
| Regulation Number | 886.5916 |
| Applicant | BAUSCH & LOMB |
| PMA Number | P010062 |
| Supplement Number | S001 |
| Date Received | 07/06/2004 |
| Decision Date | 08/02/2004 |
| Product Code | |
| Advisory Committee |
Ophthalmic |
| Supplement Type | real-time process |
| Supplement Reason | other |
| Expedited Review Granted? | No |
| Combination Product |
No
|
Approval Order Statement Approval for the protocol to be used to add contact lens finishing laboratories to manufacture the subject device. The device, as modified, will be marketed under the trade name boston orthokeratology (oprifocon a) shaping lens for overnight wear for bausch & lomb vision shaping treatment and is indicated for use in the reduction of myopic refractive error in non-diseased eyes. The lenses are indicated for overnight wear for the temporary reduction of myopia up to 5. 00 diopters with eyes having astigmatism up to 1. 5 diopters. The lenses may only be disinfected using a chemical disinfection system. Note: to maintain the orthokeratology effect of myopia reduction, overnight lens wear must be continued on a prescribed schedule. Failure to do so can affect daily activities (e. G. , night driving), visual fluctuations and changes in intended correction. |
|
|